MiMedx Group (MDXG) News Today → Dems have chosen Biden replacement? (From Paradigm Press) (Ad) Free MDXG Stock Alerts $7.80 -0.09 (-1.14%) (As of 05/17/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 16 at 2:02 AM | americanbankingnews.comMiMedx Group (NASDAQ:MDXG) vs. Femasys (NASDAQ:FEMY) Head-To-Head SurveyMay 15 at 8:00 AM | globenewswire.comMIMEDX to Participate in Upcoming Investor ConferencesMay 11, 2024 | marketbeat.comMiMedx Group, Inc. (NASDAQ:MDXG) Shares Bought by Russell Investments Group Ltd.Russell Investments Group Ltd. lifted its position in shares of MiMedx Group, Inc. (NASDAQ:MDXG - Free Report) by 1,577.5% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 525,059 shares of the company's stock after buying an addiMay 3, 2024 | marketbeat.comStockNews.com Lowers MiMedx Group (NASDAQ:MDXG) to BuyStockNews.com downgraded shares of MiMedx Group from a "strong-buy" rating to a "buy" rating in a research report on Friday.May 3, 2024 | marketbeat.comEquities Analysts Set Expectations for MiMedx Group, Inc.'s FY2026 Earnings (NASDAQ:MDXG)MiMedx Group, Inc. (NASDAQ:MDXG - Free Report) - Equities researchers at Zacks Small Cap issued their FY2026 earnings estimates for MiMedx Group in a report released on Wednesday, May 1st. Zacks Small Cap analyst J. Vandermosten expects that the company will post earnings per share of $1.04 for tMay 2, 2024 | finance.yahoo.comMiMedx Group, Inc. (NASDAQ:MDXG) Q1 2024 Earnings Call TranscriptMay 2, 2024 | marketbeat.comMiMedx Group, Inc. to Post Q4 2024 Earnings of $0.11 Per Share, HC Wainwright Forecasts (NASDAQ:MDXG)MiMedx Group, Inc. (NASDAQ:MDXG - Free Report) - HC Wainwright lowered their Q4 2024 EPS estimates for shares of MiMedx Group in a research note issued on Wednesday, May 1st. HC Wainwright analyst S. Ramakanth now expects that the company will earn $0.11 per share for the quarter, down from theirMay 2, 2024 | markets.businessinsider.comBuy Rating Affirmed for MiMedx on Strong Performance and Favorable Market OutlookMay 1, 2024 | finance.yahoo.comMDXG: MACs Give Credit for EfficacyMay 1, 2024 | markets.businessinsider.comMiMedx Group: Strong Financial Performance and Future Growth Potential Affirm Buy RatingMay 1, 2024 | finance.yahoo.comQ1 2024 MiMedx Group Inc Earnings CallMay 1, 2024 | marketbeat.comMiMedx Group (NASDAQ:MDXG) Rating Reiterated by HC WainwrightHC Wainwright restated a "buy" rating and set a $11.00 target price on shares of MiMedx Group in a research report on Wednesday.May 1, 2024 | finanznachrichten.deMiMedx Group, Inc: MIMEDX Announces First Quarter 2024 Operating and Financial ResultsMay 1, 2024 | finance.yahoo.comMiMedx Group Inc (MDXG) Q1 2024 Earnings Call Transcript Highlights: Strong Financial ...April 30, 2024 | markets.businessinsider.comMDXG Stock Earnings: MiMedx Group Beats EPS, Beats Revenue for Q1 2024April 30, 2024 | globenewswire.comMIMEDX Announces First Quarter 2024 Operating and Financial ResultsApril 29, 2024 | markets.businessinsider.comMiMedx Group earnings preview: what Wall Street is expectingApril 27, 2024 | nasdaq.comMiMedx Group Enters Oversold Territory (MDXG)April 25, 2024 | marketbeat.comMiMedx Group (NASDAQ:MDXG) Shares Gap Down to $6.43MiMedx Group (NASDAQ:MDXG) Shares Gap Down to $6.43April 23, 2024 | money.usnews.comMimedx Group IncApril 23, 2024 | marketbeat.comMiMedx Group (MDXG) Set to Announce Quarterly Earnings on TuesdayMiMedx Group (NASDAQ:MDXG) will be releasing earnings after the market closes on Tuesday, April 30, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=585103)April 21, 2024 | marketbeat.comCalamos Advisors LLC Invests $3.12 Million in MiMedx Group, Inc. (NASDAQ:MDXG)Calamos Advisors LLC bought a new position in shares of MiMedx Group, Inc. (NASDAQ:MDXG - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 355,534 shares of the company'sApril 18, 2024 | fool.comMiMedx Group (NASDAQ: MDXG)April 16, 2024 | globenewswire.comMIMEDX to Host First Quarter 2024 Operating and Financial Results Conference Call on April 30April 13, 2024 | wsj.comMiMedx Group Inc.April 10, 2024 | marketbeat.comVanguard Group Inc. Acquires 250,812 Shares of MiMedx Group, Inc. (NASDAQ:MDXG)Vanguard Group Inc. grew its holdings in shares of MiMedx Group, Inc. (NASDAQ:MDXG - Free Report) by 4.1% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 6,437,155 shares of the company's stock after acquiring an additional 250,812 shares during the period.April 9, 2024 | marketbeat.comTurtle Creek Wealth Advisors LLC Takes Position in MiMedx Group, Inc. (NASDAQ:MDXG)Turtle Creek Wealth Advisors LLC acquired a new stake in MiMedx Group, Inc. (NASDAQ:MDXG - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 181,700 shares of the company's stock, valued at approximately $1,59April 2, 2024 | marketbeat.comMiMedx Group (NASDAQ:MDXG) Shares Down 7.5% MiMedx Group (NASDAQ:MDXG) Trading Down 7.5%April 1, 2024 | marketbeat.comMiMedx Group, Inc. (NASDAQ:MDXG) Receives Average Recommendation of "Buy" from AnalystsShares of MiMedx Group, Inc. (NASDAQ:MDXG - Get Free Report) have earned an average recommendation of "Buy" from the four ratings firms that are presently covering the firm, Marketbeat Ratings reports. Four research analysts have rated the stock with a buy rating. The average 12-month price targetMarch 29, 2024 | stockhouse.comMIMEDX Provides Update on AXIOFILL® Request for Designation ("RFD") from FDAMarch 27, 2024 | marketbeat.comMiMedx Group (NASDAQ:MDXG) Sees Large Volume IncreaseMiMedx Group (NASDAQ:MDXG) Sees Large Volume IncreaseMarch 27, 2024 | msn.comMiMedx slips as FDA reaffirms position on AxiofillMarch 27, 2024 | finance.yahoo.comMIMEDX Provides Update on AXIOFILL® Request for Designation (“RFD”) from FDAMarch 22, 2024 | investing.comMiMedx secures exclusive rights to wound care productMarch 21, 2024 | markets.businessinsider.comNorthland Securities Keeps Their Buy Rating on MiMedx Group (MDXG)March 21, 2024 | finance.yahoo.comInvesting in MiMedx Group (NASDAQ:MDXG) a year ago would have delivered you a 138% gainMarch 20, 2024 | markets.businessinsider.comAnalysts Conflicted on These Healthcare Names: Diamedica Therapeutics (DMAC), Design Therapeutics (DSGN) and MiMedx Group (MDXG)March 20, 2024 | globenewswire.comMIMEDX Expands Portfolio with Fibrillar Collagen Wound DressingMarch 16, 2024 | insidertrades.comMiMedx Group, Inc. (NASDAQ:MDXG) CAO Sells $162,028.95 in StockMarch 16, 2024 | finance.yahoo.comMDXG Apr 2024 7.500 callMarch 13, 2024 | finance.yahoo.comMIMEDX Introduces E-Commerce and Account Management PlatformMarch 12, 2024 | msn.comGeron slips as FDA reviews blood cancer therapy ahead of AdCom meetingMarch 12, 2024 | marketbeat.comCannell Capital LLC Has $16.58 Million Stock Holdings in MiMedx Group, Inc. (NASDAQ:MDXG)Cannell Capital LLC increased its position in shares of MiMedx Group, Inc. (NASDAQ:MDXG - Free Report) by 106.7% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 2,273,762 shares of theMarch 7, 2024 | marketbeat.comMiMedx Group, Inc. (NASDAQ:MDXG) Given Consensus Rating of "Buy" by AnalystsMiMedx Group, Inc. (NASDAQ:MDXG - Get Free Report) has received a consensus rating of "Buy" from the three analysts that are currently covering the stock, Marketbeat reports. Three investment analysts have rated the stock with a buy rating. The average 1-year price objective among brokers that havMarch 7, 2024 | marketbeat.comMiMedx Group (NASDAQ:MDXG) Coverage Initiated by Analysts at Lake Street CapitalLake Street Capital began coverage on MiMedx Group in a report on Thursday. They issued a "buy" rating and a $12.00 price objective on the stock.March 4, 2024 | finance.yahoo.comMIMEDX Announces Appointment of Two New Independent DirectorsMarch 1, 2024 | finanznachrichten.deMiMedx Group, Inc: MIMEDX Announces Fourth Quarter and Full Year 2023 Operating and Financial ResultsMarch 1, 2024 | markets.businessinsider.comMizuho Maintains Buy Rating for MiMedx Group: Here's What You Need To KnowMarch 1, 2024 | marketbeat.comMizuho Increases MiMedx Group (NASDAQ:MDXG) Price Target to $14.00Mizuho increased their price target on shares of MiMedx Group from $13.00 to $14.00 and gave the stock a "buy" rating in a research report on Friday.March 1, 2024 | finance.yahoo.comMiMedx Group Full Year 2023 Earnings: EPS Beats Expectations Get MiMedx Group News Delivered to You Automatically Sign up to receive the latest news and ratings for MDXG and its competitors with MarketBeat's FREE daily newsletter. Email Address Dems have chosen Biden replacement? (Ad)On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in the 2024 presidential election. See who it is HERE. MDXG Media Mentions By Week MDXG Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MDXG News Sentiment▼0.440.50▲Average Medical News Sentiment MDXG News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MDXG Articles This Week▼23▲MDXG Articles Average Week Get MiMedx Group News Delivered to You Automatically Sign up to receive the latest news and ratings for MDXG and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: AtriCure News Artivion News Embecta News Atrion News Silk Road Medical News Alphatec News OrthoPediatrics News Paragon 28 News SI-BONE News LeMaitre Vascular News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MDXG) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersObama’s Forever Term [exposed]Porter & CompanyThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingMost important medical advance in 100 yearsThe Oxford ClubThe Presidential candidate you should REALLY be worried aboutStansberry ResearchForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsClaim Your Complimentary Bitcoin RewardCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MiMedx Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
